BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9272392)

  • 21. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
    Barry AL; Jones RN; Gavan TL
    J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.
    Barry AL; Thornsberry C; Gavan TL; Jones RN
    J Clin Microbiol; 1984 Nov; 20(5):988-9. PubMed ID: 6439736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
    Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
    J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.
    Ross JE; Mendes RE; Jones RN
    J Clin Microbiol; 2014 Sep; 52(9):3399-401. PubMed ID: 24920777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci.
    Toma E; Barriault D
    J Clin Microbiol; 1995 Jul; 33(7):1712-5. PubMed ID: 7665633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    Barry AL; Jones RN; Gavan TL; Thornsberry C
    J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of some unsymmetrical diorganyltellurium(IV) dichlorides.
    Soni D; Gupta PK; Kumar Y; Chandrashekhar TG
    Indian J Biochem Biophys; 2005 Dec; 42(6):398-400. PubMed ID: 16955743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports.
    Cushnie TP; Hamilton VE; Lamb AJ
    Microbiol Res; 2003; 158(4):281-9. PubMed ID: 14717448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syntheses, in vitro antibacterial and cytotoxic activities of a series of 3-substituted succinimides.
    Zentz F; Le Guillou R; Labia R; Sirot D; Linard B; Valla A
    Farmaco; 2004 Nov; 59(11):879-86. PubMed ID: 15544792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
    Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
    Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Fosfomycin Etest To Determine
    Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
    J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
    Odland BA; Erwin ME; Jones RN
    J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interlaboratory quality control of the agar diffusion test for determining sensitivity of microorganisms to antibiotics].
    Garanina EN; Givental' NI; Andreeva ZM; Verenchikova IaV; Ginzburg AI
    Lab Delo; 1984; (1):43-6. PubMed ID: 6199568
    [No Abstract]   [Full Text] [Related]  

  • 37. [Susceptibility testing with fosfomycin in an agar diffusion test on Mueller-Hinton agar].
    Grimm H; Haag R
    Immun Infekt; 1982 Jul; 10(4):159-63. PubMed ID: 6813250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of 2 automated microdilution techniques compared to an agar dilution method in determining sensitivity to fosfomycin in strains of carbapenem-resistant Pseudomonas aeruginosa].
    Gil-Romero Y; Regodón-Domínguez M; Wilhelmi de Cal I; López-Fabal F; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin; 2016; 34(7):406-8. PubMed ID: 26620604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
    Smith EC; Brigman HV; Anderson JC; Emery CL; Bias TE; Bergen PJ; Landersdorfer CB; Hirsch EB
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32669380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative studies on activities on antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Hirose T; Matsukawa M; Takahashi S; Kunishima Y; Fujime M; Fujita K; Ogihara M; Ishibashi K; Igari J; Shigeta S; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Yoshida H; Imafuku Y; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Kitamura M; Takano Y; Matsuoka Y; Matsuda S; Sato S; Furuhama T; Kumon H; Monden K; Kohno S; Miyazaki Y; Tomono K; Aoki S; Mochida C; Hirakata Y
    Jpn J Antibiot; 2002 Oct; 55(5):568-655. PubMed ID: 12532638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.